VivoSim Labs (VIVS) FCF Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
VivoSim Labs (VIVS) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 175.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 345.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 400.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 718.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -1,644.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -12,458.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 3,304.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -9,606.00 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -1.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.09 Mn |
| Mar 31, 2026 | -254,590.00 |
| Dec 31, 2025 | -642,196.00 |
| Sep 30, 2025 | -545,909.00 |
| Mar 31, 2025 | -388,393.00 |
| Dec 31, 2022 | -215,932.00 |
| Sep 30, 2022 | -261,466.00 |
| Mar 31, 2022 | 64,653.00 |
| Dec 31, 2019 | 46,978.00 |
| Sep 30, 2019 | 7,566.00 |
| Jun 30, 2019 | 7,146.00 |
| Mar 31, 2019 | 69,520.00 |
| Dec 31, 2018 | 164,666.00 |
| Sep 30, 2018 | 254,395.00 |
| Jun 30, 2018 | 140,895.00 |
| Mar 31, 2018 | 182,448.00 |
| Dec 31, 2017 | 240,913.00 |
| Sep 30, 2017 | 253,837.00 |
| Jun 30, 2017 | 256,222.00 |
| Sep 30, 2016 | 449,128.00 |